Evaluation of the immune status of horses with and without equine keratoconjunctivitis in particular consideration of an EHV-2 infection;Ermittlung des Immunstatus bei Pferden mit bzw. Ohne Equine Keratokonjunktivitis unter Besonderer Berücksichtigung Einer EHV-2-lnfektion

Tierarztliche Praxis Ausgabe G: Grosstiere - Nutztiere

Volumn 35, Issue 5, 2007, Pages 356-362

  Fetsch, A ^a   Huebner, J ^b   Langbein, I ^b   Mueller, E ^b   Borchers, K ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b LABOKLIN GMBH AND CO KG   (Germany)

Author keywords

B cells; Equine herpes virus type 2 (EHV 2); Flow cytometry; Horse; Keratoconjunctivitis; T cells

Indexed keywords

ANIMALIA; EQUID HERPESVIRUS 1; EQUID HERPESVIRUS 2; EQUIDAE; HUMAN HERPESVIRUS 2;

EID: 35748980027     PISSN: 14341220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621643     Document Type: Review

References (36)

1. Ackermann M. Pathogenesis of gammaherpesvirus infections. Vet Microbiol 2006; 113: 211-222.
2. Allan GM, Kennedy S, McNeilly F, Foster JC, Ellis JA, Krakowka SJ, et al. Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol 1999; 121: 1-11.
3. Bagust TJ, Pascoe RR, Harden TJ. Studies on equine herpesviruses 3. The incidence in Queensland of three different equine herpesvirus infections. Aust Vet J 1972; 48:47-53.
4. Besthorn C. Keratitiden des Pferdes und Nachweishäufigkeit der DNS der Equinen Herpesviren Typ 2 (EHV-2) und Typ 5 (EHV-5) mittels Polymerasekettenreaktion. Diss, Ludwig-Maximilians-Universität München 2002.
5. Borchers K, Brackmann J, Kershaw O. The mouse is not permissive for equine herpesvirus 2 (EHV-2), however viral DNA persisted in lung and spleen depending on the inoculation route. Arch Virol 2002; 147: 1437-1444.
6. Borchers K, Ebert M, Fetsch A, Hammond T, Sterner-Kock A. Prevalence of equine herpesvirus type 2 (EHV-2) DNA in ocular swabs and its cell tropism in equine conjunctiva. Vet Microbiol 2006; 118: 260-266.
7. Borchers K, Wolfinger U, Goltz M, Broll H, Ludwig H. Distribution and relevance of equine herpesvirus type 2 (EHV-2) infections. Arch Virol 1997; 142: 917-928.
8. Borchers K, Wolfinger U, Ludwig H, Thein P, Baxi S, Field HJ, et al. Virological and molecular biological investigations into equine herpes virus type 2 (EHV-2) experimental infections. Virus Res 1998; 55: 101-106.
9. Browning GF, Studdert MJ. Equine herpesvirus 2 (equine cytomegalovirus). Vet Bull 1988; 58: 775-790.
10. Chaffin MK, Cohen ND, Martens RJ, Edwards RF, Nevill M, Smith R. Hematologic and immunophenotypic factors associated with development of rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection. Vet Immunol Immunopathol 2004; 100: 33-48.
11. Collinson PN, O'Rielly JL, Ficorilli N, Studdert MJ. Isolation of equine herpesvirus type 2 (equine gammaherpesvirus 2) from foals with keratoconjunctivitis. J Am Vet Med Assoc 1994; 205: 329-331.
12. Davis EG, Wilkerson MJ, Rush BR. Flow cytometry: clinical applications in equine medicine. J Vet Intern Med 2002; 16: 404-410.
13. Drummer HE, Reubel GH, Studdert MJ. Equine gammaherpesvirus 2 (EH V-2) is latent in B-lymphocytes. Arch Virol 1996; 141: 495-504.
14. Erpenstein C, Sieben M, Failing K, Herbst W Untersuchungen zum Vorkommen nosokomialer Virusinfektionen bei stationären Patienten mit unterschiedlichem Impfstatus in einer tierärztlichen Klinik für Pferde. Tierärztl Prax 2002; 30 (G): 32-38.
15. Fu ZF, Robinson AJ, Horner GW, Dickinson LG, Grimmett JB, Marshall RB. Respiratory disease in foals and the epizootiology of equine herpesvirus type 2 infections. N Z Vet J 1986; 34: 152-155.
16. Jungi T, Hrsg. Klinische Veterinärimmunologie. Stuttgart: Enke 2000.
17. Kershaw O, Von Oppen T, Glitz F, Deegen E, Ludwig H, Borchers K. Detection of equine herpesvirus 2 (EHV-2) in horses with keratoconjunctivitis. Virus Res 2001;80:109-115.
18. Kraft W, Dürr U, Hrsg. Klinische Labordiagnostik in der Veterinärmedizin. Stuttgart, New York: Schattauer 2005.
19. Krüdewagen EM, Balzer HJ, Kellner SJ. Nachweishäufigkeit von Equinen Herpesviren 2 und 5 am Pferdeauge - Vergleich der Nachweismö glichkeiten mittels exfoliater Zytologie und Polymerasekettenreaktion. Pferdeheilk 2001; 17: 444452.
20. Langbein I, Kühnlein P, Schimmer C, Vahlenkamp TW, Huebner J, Mueller E. Durchflusszytometrische Bestimmung der Lymphozytensubpopulationen im peripheren Blut von Hunden und Katzen. Tierärztl Prax 2003; 31 (K): 537-546.
21. Matthews AG, Handscombe MC. Superficial keratitis in the horse: treatment with the antiviral drug idoxuridine. Equine Vet J Suppl 1983; 138-140.
22. Merant C, Bonnefont C, Debos A, Greenland T, Cadore JL, Monier JC. Cross-species reactivity of seven monoclonal antibodies with equine lymphocytes by flow cytometry. Vet Res 2003; 34: 791-801.
23. Miller TR, Gaskin JM, Whitley RD, Wittcoff ML. Herpetic keratitis in a horse. Equine Vet J Suppl 1990; 15-17.
24. Murakami K, Sentsui H, Shibahara T, Yokoyama T. Reduction of CD4+ and CD8+ t- lymphocytes during febrile periods in horses experimentally infected with equine infectious anemia virus. Vet Immunol lmmunopathol 1999;67:131-140.
25. Murray MJ, Eichorn ES, Dubovi EJ, Ley WB, Cavey DM. Equine herpesvirus type 2: prevalence and seroepidemiology in foals. Equine Vet J 1996; 28: 432-436.
26. Nordengrahn A, Rusvai M, Merza M, Ekstrom J, Morein B, Belák S. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes. Vet Microbiol 1996; 51: 55-68.
27. Pálfi V, Belák S, Molnar T. Isolation of equine herpesvirus type 2 from foals showing respiratory svmptoms. Zentralbl Veterinarmed B 1978; 25: 165-167.
28. Rode HJ, Bugert JJ. Handermann M, Schnitzler P, Kehm R, Janssen W, et al. Molecular characterization and determination of the coding capacity of the genome of equine herpesvirus type 2 between the genome coordinates 0.235 and 0.258 (the EcoRI DNA fragment N; 4.2 kbp). Virus Genes 1994; 9: 61-75.
29. Sarli G, Mandriolo L, Laurenti M, Sidoli L, Cerati C, Rolla G, et al. Immunohistochemical characterisation of the lymph node reaction in pig postweaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol 2001; 83: 53-67.
30. Schlocker N, Gerber-Bretscher R, Von Fellenberg R. Equine herpesvirus 2 in pulmonary macrophages of horses. Am J Vet Res 1995; 56: 749-754.
31. Segales J, Domingo M. Postweaning multisystemic wasting syndrome (PMWS) in pigs. A review. Vet Q 2002; 24: 109-124.
32. Telford EAR, Studdert MJ, Agius CT, Watson MS, Aird HC, Davison AJ. Equine herpesviruses 2 and 5 are gamma-herpesviruses. Virology 1993; 195: 492499.
33. Thein P, Böhm D. Ätiologie und Klinik einer virusbedingten Keratokonjunktivitis beim Fohlen. Zentralbl Veterinarmed B 1976; 23: 507-519.
34. Turner AJ, Studdert MJ, Peterson JE. Equine herpes virases. 2. Persistence of equine herpesviruses in experimentally infected horses and the experimental induction of abortion. Aust Vet J 1970; 46: 90-98.
35. Von Borstel M. Erweiterte Diagnostikverfahren bei Keratitiden des Pferdes unter besonderer Berücksichtigung der Nachweishäufigkeit des equinen Herpesvirus Typ 2 (EHV-2). Diss, Tierärztliche Hochschule Hannover 2003.
36. Von Oppen T, Kershaw O, Borchers K, Glitz F, Boevé MH. Keratitiden des Pferdes und Nachweis von equinem Herpesvirus Typ 2 (EHV-2). Tierärztl Prax 2001; 29 (G): 227-233.